NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$379.68
−2.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 305.12x
- P/S forward
- 16.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 30.05x
- Price / sales
- 20.22x
- Price / cash flow
- 239.79x
Enterprise value
- Enterprise value
- $53.9B
- EV / sales
- 19.90x
- EV / EBITDA
- -301.47x
- EV / EBIT
- -185.99x
- Market cap
- $54.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026